News-Medical.Net July 29, 2024
In a recent review published in the journal Obesity Pillars, a team of researchers collate and narratively review the literature on the dietary impacts of obesity or type 2 diabetes (T2D) patients undergoing glucagon-like peptide receptor agonists (GLP-1RAs) or glucose-dependent insulinotropic polypeptide/glucagon-like peptide receptor agonists (GIP/GLP-1RAs) clinical interventions.
Their findings highlight a significant shortage of available information, with only a limited amount of previously published studies meeting their review inclusion criteria. Furthermore, while these interventions achieve notable reductions in total caloric intakes (16-39%), dietary composition is rarely scientifically evaluated in receptor agonist studies. The authors recommend future studies to assess the protein and essential micronutrient intake change following GLP-1 or GIP/GLP-1 interventions and include a registered dietitian nutritionist (RDN) in...
Today's Sponsors
Today's Sponsor